title: Letrozole Potentiates Mitochondrial and Dendritic Spine Impairments Induced by β Amyloid.
abstract: Reduced estrogens, either through aging or postsurgery breast cancer treatment with the oral nonsteroidal aromatase inhibitor letrozole, are linked with declined cognitive abilities. However, a direct link between letrozole and neuronal deficits induced by pathogenic insults associated with aging such as beta amyloid (Aβ 1-42) has not been established. The objective of this study was to determine if letrozole aggravates synaptic deficits concurrent with Aβ 1-42 insult. We examined the effects of letrozole and oligomeric Aβ 1-42 treatment in dissociated and organotypic hippocampal slice cultures. Changes in glial cell morphology, neuronal mitochondria, and synaptic structures upon letrozole treatment were monitored by confocal microscopy, as they were shown to be affected by Aβ 1-42 oligomers. Oligomeric Aβ 1-42 or letrozole alone caused decreases in mitochondrial volume, dendritic spine density, synaptophysin (synaptic marker), and the postsynaptic protein, synaptopodin. Here, we demonstrated that mitochondrial and synaptic structural deficits were exacerbated when letrozole therapy was combined with Aβ 1-42 treatment. Our novel findings suggest that letrozole may increase neuronal susceptibility to pathological insults, such as oligomeric Aβ 1-42 in Alzheimer's disease (AD). These changes in dendritic spine number, synaptic protein expression, and mitochondrial morphology may, in part, explain the increased prevalence of cognitive decline associated with aromatase inhibitor use.
authors: Department of Pharmacology and Therapeutics, Faculty of Medicine, McGill University, 3655 Promenade Sir William Osler, Montreal, QC, Canada H3G 1Y6.
authors: P K-Y
authors: PK
authors: Chang
authors: S
authors: S
authors: Boridy
authors: R A
authors: RA
authors: McKinney
authors: D
authors: D
authors: Maysinger
references: Neurobiol Dis. 2012 Jan;45(1):479-87
references: 21945538
references: Nat Neurosci. 2010 Feb;13(2):190-6
references: 20037574
references: Science. 2012 Aug 31;337(6098):1062-5
references: 22936770
references: Mol Brain. 2010 Mar 26;3:10
references: 20346152
references: J Physiol. 2007 May 15;581(Pt 1):129-38
references: 17303644
references: Am J Psychiatry. 2003 Aug;160(8):1522-4
references: 12900319
references: J Alzheimers Dis. 2013;33 Suppl 1:S253-62
references: 22531428
references: Nat Neurosci. 2001 Nov;4(11):1086-92
references: 11687814
references: Sci Signal. 2009 May 05;2(69):pe29
references: 19417214
references: Acta Neuropathol. 2010 Jan;119(1):7-35
references: 20012068
references: J Neurosci. 2012 Nov 14;32(46):16129-40
references: 23152597
references: Nat Neurosci. 2008 Mar;11(3):334-43
references: 18297067
references: J Neurosci. 2012 Jun 13;32(24):8116-26
references: 22699893
references: Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3112-6
references: 18287015
references: Obstet Gynecol. 1998 Mar;91(3):459-66
references: 9491878
references: Neurobiol Aging. 2013 Apr;34(4):1080-9
references: 23122920
references: Nat Neurosci. 1999 Jan;2(1):44-9
references: 10195179
references: J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):405-12
references: 14623538
references: Psychopharmacology (Berl). 2000 Apr;149(2):129-39
references: 10805607
references: Neuroscience. 2000;101(3):485-512
references: 11113299
references: J Aging Res. 2011;2011:251517
references: 21969914
references: Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S123-9
references: 19781860
references: Hippocampus. 2011 Dec;21(12):1263-7
references: 20928832
references: Cancer. 2007 Jul 15;110(2):244-54
references: 17538978
references: Biomaterials. 2009 Oct;30(29):5583-91
references: 19577802
references: Nat Neurosci. 2011 Mar;14(3):285-93
references: 21346746
references: Biochim Biophys Acta. 2010 Oct;1800(10):1113-20
references: 19931595
references: Mol Neurobiol. 2012 Aug;46(1):151-60
references: 22678467
references: Psychoneuroendocrinology. 1999 Oct;24(7):727-41
references: 10451908
references: J Steroid Biochem Mol Biol. 1996 Jul;58(4):411-5
references: 8903425
references: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18670-5
references: 20937894
references: J Neurosci. 2009 Jan 28;29(4):1017-33
references: 19176811
references: Curr Neurol Neurosci Rep. 2010 Sep;10(5):359-66
references: 20535591
references: J Neural Transm (Vienna). 2009 Nov;116(11):1417-25
references: 19730783
references: Biochim Biophys Acta. 2010 Oct;1800(10):1077-83
references: 19913598
references: Int J Alzheimers Dis. 2011;2011:305395
references: 21922047
references: J Steroid Biochem Mol Biol. 2003 Oct;87(1):35-45
references: 14630089
references: J Neurosci. 2007 Nov 28;27(48):13357-65
references: 18045930
references: Trends Neurosci. 1997 Oct;20(10):471-7
references: 9347615
references: PLoS One. 2012;7(2):e32737
references: 22393443
references: Nat Neurosci. 2003 May;6(5):491-500
references: 12692557
references: Neuron. 2006 Dec 7;52(5):831-43
references: 17145504